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Abstract
Background: Affymetrix GeneChips can be re-annotated at the probe-level by breaking up the
original probe-sets and recomposing new probe-sets based on up-to-date genomic knowledge,
such as available in Entrez Gene. This results in custom Chip Description Files (CDF). Using these
custom CDFs improves the quality of the data and thus the results of related gene expression
studies. However, 44–71% of the probes on a GeneChip are lost in this re-annotation process.
Although generally aimed at less known genes, losing these probes obviously means a substantial
loss of expensive experiment data. Biologists are therefore very reluctant to adopt this approach.
Findings: We aimed to re-introduce the non-affected Affymetrix probe-sets after these re-
annotation procedures. For this, we developed an algorithm (CDF-Merger) and applied it to
standard Affymetrix CDFs and custom Brainarray CDFs to obtain Hybrid CDFs. Thus, salvaging
lost Affymetrix probes with our CDF-Merger restored probe content up to 94%. Because the
salvaged probes (up to 54% of the probe content on the arrays) represent less-reliable probe-sets,
we made the origin of all probe-set definitions traceable, so biologists can choose at any time in
their analyses, which subset of probe-sets they want to use.
Conclusion: The availability of up-to-date Hybrid CDFs plus R environment allows for easy
implementation of our approach.
Findings
Background
Affymetrix GeneChips are widely used for transcriptome
analysis. This microarray platform is based on the concept
of a set of 11–22 probes representing each gene. However,
the genomic knowledge used by Affymetrix for the origi-
nal probe-set definitions becomes increasingly outdated.
This compels the redefinition of these probe-sets at probe
level using current genomic knowledge. Several studies
addressed this issue [1-4]. In these approaches, the origi-
nal probe-set definitions are discarded and all probes are
recomposed into new probe-sets by mapping each probe
via their sequence to unique genes available in one or
more well-defined genomics resources (Entrez Gene, Ref-
seq, Ensembl). The approaches differ with respect to the
used genomic resources and genetic elements (genes or
transcripts), as well as the chosen parameters, such as
minimum number of probes per probe-set, percentage
sequence similarity, and so on. In order to make these
new probe-sets available to life scientists, new Affymetrix
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compatible custom Chip Description Files (CDFs) are
produced that contain probe-sets, each consisting of a few
to several hundreds probes.
Because these custom CDFs are based on the latest
genomic knowledge, the newly defined probe-sets per-
form better in gene-profiling studies [5,6] or allow for
more reliable cross-platform comparison of gene expres-
sion [4]. Also, since genes are uniquely represented in a
custom CDF, bias towards genes represented by multiple
probe-sets is avoided in gene-set enrichment. With these
advantages, one would expect these probe re-annotation
approaches to be readily embraced by the research com-
munity. Although there is an increasing interest for this
issue, still a limited number of studies actually used such
an approach [7-11]. One of the reasons might be that cus-
tom CDFs require a somewhat more advanced bioinfor-
matics environments, both in software and expertise.
As we experience in practice, biologists do not accept the
low percentages of probes left after re-annotation (Table
1). Given the costly nature of Affymetrix based experi-
ments, they will not easily discard 44–71% of their data,
even though they know that the quality of the annotation
of these probe sets is poor. They want to keep these probes
sets because commonly their studies are not focussed only
on well-established genes, but also on the involvement of
new (poorly-annotated) genes. Quite often even their
favourite genes are absent in the custom CDFs. In fact,
some biologists fix the loss of their favourite genes by
reintroducing them using the old Affymetrix probe-set
definition [10]. This entails two separate, but redundant
analyses that are difficult to compare. This motivated us to
merge these two analyses from the start, by salvaging as
many probe-sets as possible that are lost during probe re-
annotation. To illustrate our point, in the study described
in [10], a number of genes involved in epileptogenic
development, such as Kncd2, a Potassium channel pro-
tein and CD11b/c (OX42), a marker for microglial activa-
tion are absent in the Brainarray CDF. These genes were
added to the analyses and proved to be important in the
biological study at hand. Currently, analyses of several
Affymetrix experiments are in progress using our Hybrid
CDFs.
Here we present a procedure, CDF-Merger, to formally
compose such hybrid probe-set definitions based on the
Brainarray approach by [1]. Thus, we generate Hybrid
CDFs in which Entrez gene defined genes are uniquely
represented and probe usage is maximized by reusing the
information provided by Affymetrix, as long as there is no
conflict with the Brainarray probe-sets. Given the differ-
ence in annotation quality between custom CDF annota-
tion and original Affymetrix annotation, we made the
origin of probe-set definitions in the Hybrid CDFs tracea-
ble by extensions on probe-set ids. In this way, biologist
can choose at any time during their analysis which gene
set they would like to use. Hybrid CDFs are Entrez based,
i.e. gene-centric. If at some point in the analysis, a more
transcript-centric approach is needed, tools such as
ADAPT [12] can be used to link identifiers in the Hybrid
CDF by their Affymetrix or Entrez Gene IDs via Ensembl
to their transcripts.
Description
Hybrid probe-set definitions are generated using Brainar-
ray CDFs [13], Affymetrix NetAffx Annotation Files[14],
and NCBI Entrez Gene Info Files[15]. The original proce-
dure to generate custom Brainarray Entrez probe sets
entails the mapping of each -perfect match- Affymetrix
probe to the appropriate Entrez Gene annotated target
sequences. Probes with more than one or no perfect hits
are removed and each final probe set must contain at least
three probes [1].
The following CDF-Merger algorithm aims to salvage a
maximum number of probes from Affymetrix GeneChips
that are lost by Brainarray re-annotation:
a. Rename the Brainarray defined probe-sets from a spe-
cific Brainarray CDF to allow future traceability: Hybrid
probe-set id: atd_ [Entrez id]
b. Check each Brainarray defined probe-set for probes also
present in other Brainarray probe-sets. If so, mark such a
probe-set with extension _d.
c. Keep the Affymetrix defined probe-set names from the
relevant Affymetrix NetAffx Annotation File to allow
Table 1: Percentage of probe usage after re-annotation
Organism GeneChip Affymetrix Brainarray [1] AffyProbe-Miner * [3] Hybrid
H. sapiens** HG-U133_Plus_2 604,258 40% 56% 94%
M. musculus Mouse430_2 496,468 49% 56% 94%
R. norvegicus Rat230_2 342,410 40% 29% 94%
B. taurus Bovine 265,627 44% 29% 93%
D. rerio Zebrafish 249,752 39% 46% 88%
* Gene Consistent RefSeq plus GenBank, min. probe-set size = 5.
** GeneAnnot [2]: 58% probe usage.BMC Research Notes 2008, 1:66 http://www.biomedcentral.com/1756-0500/1/66
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future traceability: Hybrid probe-set id: AFFX-* or *_at(=
original Affymetrix id)
d. Check each Affymetrix defined probe-set and discard
those with more than two probes that are also used in the
Brainarray probe-sets.
e. Check if in the remaining probe-sets from step d, one or
two probes are also used in Brainarray probe-sets. If so,
keep the probe-set but remove these probes. If so, mark the
Hybrid probe-set _1 or _2, respectively.
f. Use the NCBI Entrez Gene Info File to check if in the
Affymetrix NetAffx Annotation file, the remaining
Affymetrix probe-sets have exactly one valid Entrez id. If
not, remove all Entrez ids from the annotation of these
Affymetrix probe-sets.
g. Check whether the Entrez id of the remaining Affyme-
trix probe-sets with one valid Entrez id also occurs in the
Brainarray CDF. If so, remove this Entrez id from the
annotation of these Affymetrix probe-sets.
h. Rename all Affymetrix probe-sets retained in steps f and
g, to allow future traceability: Hybrid probe-set id: atm_
[Entrez id]
i. Merge the Affymetrix probe-sets from step h with the
same Entrez id. Mark merged probe-sets with extension _m.
j. Compile a Hybrid CDF and R environment with these
hybrid probe-set definitions and associated annotations.
A flowchart of this CDF-Merger algorithm can be found in
supplementary information (Figure 1). The Hybrid CDFs,
the source code of the CDF-Merger algorithm, and instruc-
tions on use of these environments in R are online availa-
ble.
Concluding Remarks
The motivation for the development of our CDF-Merger
algorithm and the resulting Hybrid CDFs, came from
complaints of biologists that disliked the high percentages
of Affymetrix GeneChip probes lost during re-annotation.
To illustrate their point, we compared probe usage of two
recently published re-annotation algorithms for five com-
monly used Affymetrix GeneChips (Table 1). In the listed
alternative probe-set definitions, the amount of data at
the probe level is dramatically decreased compared to the
original Affymetrix probe-set definitions, because 44% to
71% of probes are discarded. In contrast, because we sal-
vage the far majority of lost probes with our CDF-Merger
approach, ultimately only 6% to 12% of all probes are dis-
carded. These mostly represent probes from Affymetrix
defined probe-sets for genes that are already covered by
Brainarray defined probe sets. The source code of the
CDF-Merger algorithm, definition origin, and probe-set
sizes in all Hybrid CDFs [see Additional File 1 Table S1],
a table of probe distribution [see Additional File 2 Table
S2] are online available and allow easy updating of the
Hybrid CDFs. Although we based our CDF-Merger algo-
rithm on the Brainarray re-annotation, our approach is,
with minor adjustments, also applicable to the Affy-
ProbeMiner and GeneAnnot reannotations.
It is obvious that re-introducing Affymetrix probe-sets will
dilute the data quality enhancement from the original
custom re-annotation procedures, which are based on up-
to-date genomic knowledge. However, our hybrid
approach, which is in essence a practical compromise,
aims to get the concept of re-annotated probe-sets more
widely accepted in the biology community. For this, we
made the whole CDF-Merger algorithm traceable, so it is
clear where each probe-set originates from. As such, biol-
ogists and bioinformaticians can decide at any time dur-
ing their extensive bioinformatics analyses whether they
would like to use a) limited, but well-established data, or
b) all data, which contains more ambiguity, but also more
unknown genes and transcripts. The impact of using the
Hybrid CDFs strongly depends on the character of a
microarray study and the applied bioinformatics analysis
methods. Altogether, we think that our hybrid CDF-
Merger approach, which salvages most lost probes after
probe-level re-annotation, combines the best of both
worlds to enable the often discovery-driven omics experi-
mentation.
Availability and requirements
￿ Project name: Hybrid CDF
￿  Project home page: http://mad-db.science.uva.nl/
~wdeleeuw/HybridAnnot/
Programming language: R
￿ Other requirements: BioConductor affy library
￿ Source code:
￿ http://mad-db.science.uva.nl/~wdeleeuw/HybridAn
not/genhybridannot_v1.tar.gz
￿ CDF files, R cdf environments, R annotation environ-
ments:  http://mad-db.science.uva.nl/~wdeleeuw/Hybri
dAnnot/version5.html
All files will be updated after Brainarray release.
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CDF-Merger Algorithm Figure 1
CDF-Merger Algorithm. Schema of the CDF-Merger algorithm.Publish with BioMed Central    and   every 
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